| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO | Director | Chief Executive Officer +4 more
4 companies
Foehr Matthew W is a President And CEO at OABI with holdings across 4 companies. Recent SEC Form 4 filings include 3 buys and 4 sells.
Estimated insider holdings value: $57.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 8, 2016 | AIXC Aixcrypto Holdings, Inc. | Director | Buy | 13,000 | $1.64 | $21,320.00 | +325.0% | |
| Jun 26, 2015 | LGND Ligand Pharmaceuticals Inc | President And COO | Sale+OE | 12,500 | $100.97 | $1,262,125.00 | -15.1% | |
| Jun 24, 2015 | AIXC Aixcrypto Holdings, Inc. | Director | Buy | 4,000 | $5.00 | $20,000.00 | New | |
| Jun 22, 2015 | LGND Ligand Pharmaceuticals Inc | President And COO | Sale+OE | 23,046 | $96.45 | $2,222,814.62 | -9.2% | |
| May 4, 2015 | VKTX Viking Therapeutics, Inc. | Director | Buy | 6,250 | $8.00 | $50,000.00 | New |